Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2016

View Archived Issues

First preclinical data demonstrate mutant EGFR selectivity of new inhibitor

Novel antibody mixture inhibits tumor growth in MET-amplified models

Bayer Pharma presents preclinical data for the novel anti-TweakR antibody, BAY-356

Pfizer presents highlights of first quarter 2016

Ohr Pharmaceutical develops biodegradable microparticle AMD treatment OHR-3031

Stevia First to become Vitality Biopharma with focus on cannabinoid prodrugs

Cynata Therapeutics and apceth enter license option agreement

Aptinyx completes series A financing

Interim data from Avelas' phase Ib trial of AVB-620 surgical marker

Verona Pharma announces positive phase II results for RPL-554 in patients with COPD

WAVE advances exon 51 DMD candidate and extends research collaboration with University of Oxford

Galapagos initiates phase I trial of its potentiator compound GLPG-2451

CJ CheilJedang reports compounds to treat constipation

Vitae Pharmaceuticals discloses RORgamma inverse agonists

Dermira discloses phase II results for DRM-01

Ferrer to acquire Alexza Pharmaceuticals

Achaogen enters antibody collaboration with Crystal Bioscience

Iron chelator Apo-6856 improves memory in Alzheimer's disease model

Sun Pharma Advanced Research initiates phase I/II study of K-0706

MacroGenics and Pfizer announce first patient dosed with PF-0661008

Janssen plans phase IIb study of AL-335, odalasvir and simeprevir combinations for chronic HCV

FDA grants fast track status to KemPharm's KP-511

New pilot study explores use of ARA-290 for diabetic macular edema

US Phytotherapy conducting preclinical studies of PROACT-Z for Zika infection

Treating Leber's congenital amaurosis type 10 with RNA antisense oligonucleotide QR-110

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Sun Pharma to acquire Merck spinoff Organon for $11.75B
BioWorld
Sun Pharmaceuticals Industries Ltd. will pay $11.75 billion cash to acquire Organon & Co. The transaction is expected to close in early 2027. The addition of...